When more than one process affects the brain

More than one thing can be true

Modern tests can identify some biological changes with increasing accuracy. An amyloid PET scan or Alzheimer's blood biomarker, for example, may provide real evidence that Alzheimer's pathology is present.

Presence and explanation are not identical. A test may establish that one process exists without showing how much it contributes to a person's current symptoms. Another process may be contributing alongside it.

The central clinical questions are:

• What is present?
• Which process best matches the symptoms?
• Could several processes be contributing together?
• Which findings change care now?

Which processes commonly coexist?

Alzheimer's disease and vascular injury

Small strokes, larger strokes, bleeding, and disease of the brain's small blood vessels can affect thinking and movement. These changes often coexist with amyloid and tau pathology, especially later in life.

An MRI can show many forms of vascular injury, but the amount visible on a scan does not automatically reveal how much it contributes to a person's symptoms. Location, timing, and the clinical pattern all matter.

Alzheimer's disease and Lewy body disease

Lewy body disease is associated with abnormal accumulation of a protein called alpha-synuclein. It may produce fluctuations in attention, visual hallucinations, dream-enactment behavior, movement changes, or sensitivity to certain medications.

Alzheimer's and Lewy body pathology can occur in the same brain. A person may therefore have a positive Alzheimer's biomarker and still have important symptoms that point toward Lewy body disease.

Alzheimer's disease and TDP-43-related disease

TDP-43 is a protein involved in several neurodegenerative conditions. In very late life, a pattern called limbic-predominant age-related TDP-43 encephalopathy, or LATE, can affect memory and resemble Alzheimer's disease.

LATE can occur by itself or alongside Alzheimer's pathology. There is not yet a routine clinical biomarker that confirms LATE during life, so its contribution may remain uncertain.

Other combinations

Other protein changes and structural injuries can also overlap. The possible combinations become more common with increasing age, but mixed pathology is not limited to the oldest adults.

Why do tests sometimes disagree with the symptoms?

Different tests look at different levels of the problem.

• Cognitive testing describes which abilities are working well and which are changing.
• MRI shows structure, patterns of volume loss, and vascular injury.
• FDG PET shows patterns of brain metabolism.
• Amyloid, tau, and selected blood or spinal fluid biomarkers look for particular biological processes.

A test can answer its own question accurately while leaving another question unanswered. An amyloid test may correctly show amyloid, while the pattern of language, behavior, movement, or fluctuation suggests that amyloid is not the only contributor.

Some brain processes are also easier to measure during life than others. We have increasingly useful tools for Alzheimer's pathology. We have fewer routine tools for TDP-43 and for identifying the exact protein behind many FTD-related syndromes.

What does a positive Alzheimer's biomarker tell us?

It tells us that Alzheimer's-related biology is likely to be present, assuming the test was appropriate and performed accurately. It does not, by itself, tell us:

• whether Alzheimer's is the only cause of symptoms;
• which symptoms are caused by Alzheimer's;
• how quickly the condition will change;
• how much difficulty a person currently has;
• whether another disease is also present.

The result becomes more informative when it matches the history, cognitive profile, examination, and imaging. When it does not match, the mismatch is not something to ignore. It may be a clue that the picture is more complex.

Does mixed pathology change care?

It can. Recognizing more than one contributor may change which symptoms are treated, which medications require caution, which rehabilitation services are helpful, and which safety issues deserve attention.

It may also allow several parts of health to be addressed at once. A person with Alzheimer's pathology and vascular injury may still benefit from careful management of blood pressure, diabetes, cholesterol, sleep, physical activity, and stroke risk. Someone with movement, sleep, or hallucination symptoms may need a plan that goes beyond memory treatment.

Perfect certainty is not required before useful care begins. Symptoms, safety, function, and family support can be addressed while the biological explanation continues to develop.

A diagnosis can become more precise over time

A diagnosis is often a working explanation built from the best available evidence. New symptoms, repeat cognitive testing, imaging, or biomarkers may change the weight given to each possible contributor.

That is not a failure of the earlier evaluation. It reflects the fact that brain diseases unfold over time and that our tests do not measure every process equally well.

The useful way to hold the diagnosis

The goal is not to collect as many labels as possible. It is to build the most accurate explanation of what is changing in this person and use that explanation to make better decisions.

Sometimes one disease accounts for the story. Sometimes the most honest and useful answer includes more than one.